Total Payments
$1,205
2023 Payments
$242.68
Companies
24
Transactions
59
Medicare Patients
428
Medicare Billing
$32,026
Payment Breakdown by Category
Food & Beverage$1,205 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,205 | 59 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boston Scientific Corporation | $140.66 | 1 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $136.25 | 8 | $0 (2023) |
| GENZYME CORPORATION | $96.58 | 6 | $0 (2023) |
| GlaxoSmithKline, LLC. | $95.70 | 6 | $0 (2023) |
| Amgen Inc. | $91.28 | 4 | $0 (2023) |
| United Therapeutics Corporation | $89.82 | 4 | $0 (2023) |
| Regeneron Healthcare Solutions, Inc. | $88.28 | 5 | $0 (2023) |
| Actelion Pharmaceuticals US, Inc. | $82.58 | 4 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $42.15 | 2 | $0 (2022) |
| PFIZER INC. | $39.39 | 2 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $242.68 | 12 | Lilly USA, LLC ($31.19) |
| 2022 | $612.14 | 27 | Boston Scientific Corporation ($140.66) |
| 2021 | $258.42 | 14 | AstraZeneca Pharmaceuticals LP ($39.61) |
| 2017 | $92.17 | 6 | GlaxoSmithKline, LLC. ($36.39) |
All Payment Transactions
59 individual payment records from CMS Open Payments — Page 2 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/14/2022 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $13.35 | General |
| Category: Respiratory | ||||||
| 05/31/2022 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Food and Beverage | In-kind items and services | $13.76 | General |
| Category: Cardiology | ||||||
| 05/31/2022 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $12.86 | General |
| Category: Cardiology | ||||||
| 05/24/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $13.43 | General |
| Category: Diabetes | ||||||
| 05/17/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $11.95 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/03/2022 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $15.81 | General |
| Category: IMMUNOLOGY | ||||||
| 04/26/2022 | PFIZER INC. | PREVNAR 20 (Biological) | Food and Beverage | In-kind items and services | $22.80 | General |
| Category: VACCINES | ||||||
| 04/19/2022 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $18.54 | General |
| Category: Immunology | ||||||
| 04/12/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $21.28 | General |
| Category: Diabetes | ||||||
| 03/15/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPIRIVA RESPIMAT (Drug) | Food and Beverage | In-kind items and services | $19.77 | General |
| Category: RESPIRATORY | ||||||
| 03/01/2022 | SANOFI-AVENTIS U.S. LLC | SOLIQUA 100/33 (Biological) | Food and Beverage | In-kind items and services | $19.94 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 02/22/2022 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $18.54 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 02/15/2022 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $19.06 | General |
| Category: PAH | ||||||
| 02/08/2022 | Genentech USA, Inc. | Xolair (Biological), Esbriet | Food and Beverage | In-kind items and services | $24.14 | General |
| Category: Immunology | ||||||
| 12/21/2021 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $19.86 | General |
| Category: PAH | ||||||
| 12/14/2021 | Mylan Specialty L.P. | Yupelri (Drug) | Food and Beverage | In-kind items and services | $11.32 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 11/30/2021 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $17.95 | General |
| Category: Immunology | ||||||
| 11/23/2021 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $18.45 | General |
| 11/09/2021 | Amgen Inc. | — | Food and Beverage | In-kind items and services | $21.66 | General |
| 10/19/2021 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Food and Beverage | In-kind items and services | $21.16 | General |
| Category: Oncology | ||||||
| 09/02/2021 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $21.37 | General |
| 08/25/2021 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $12.25 | General |
| Category: Respiratory | ||||||
| 07/28/2021 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $15.72 | General |
| Category: Immunology | ||||||
| 07/14/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $12.80 | General |
| Category: RESPIRATORY | ||||||
| 06/30/2021 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $18.42 | General |
| Category: Pulmonology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 18 | 35 | $9,660 | $3,070 |
| 2022 | 2 | 39 | 59 | $15,785 | $5,657 |
| 2021 | 6 | 134 | 162 | $28,835 | $10,400 |
| 2020 | 7 | 237 | 259 | $37,667 | $12,898 |
Total Patients
428
Total Services
515
Medicare Billing
$32,026
Procedure Codes
16
All Medicare Procedures & Services
16 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 18 | 35 | $9,660 | $3,070 | 31.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 26 | 46 | $11,040 | $4,100 | 37.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 13 | 13 | $4,745 | $1,557 | 32.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 33 | 52 | $12,480 | $4,919 | 39.4% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 16 | 16 | $5,840 | $1,979 | 33.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 21 | 25 | $4,125 | $1,589 | 38.5% |
| 94729 | Measurement of lung diffusing capacity | Office | 2021 | 22 | 25 | $3,318 | $1,145 | 34.5% |
| 94060 | Measurement and graphic recording of the amount and speed of breathed air, before and following medication administration | Office | 2021 | 22 | 23 | $3,030 | $767.88 | 25.3% |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | Office | 2021 | 20 | 21 | $42.00 | $0.63 | 1.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 28 | 35 | $8,400 | $2,991 | 35.6% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 23 | 23 | $8,395 | $2,906 | 34.6% |
| 94060 | Measurement and graphic recording of the amount and speed of breathed air, before and following medication administration | Office | 2020 | 52 | 57 | $7,695 | $2,604 | 33.8% |
| 94729 | Measurement of lung diffusing capacity | Office | 2020 | 56 | 57 | $7,524 | $2,478 | 32.9% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 22 | 27 | $4,455 | $1,541 | 34.6% |
| 94727 | Determination of lung volumes using gas dilution or washout | Office | 2020 | 11 | 11 | $1,100 | $375.54 | 34.1% |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | Office | 2020 | 45 | 49 | $98.00 | $1.74 | 1.8% |
About Dr. James Parosa, M.D
Dr. James Parosa, M.D is a Pulmonary Disease healthcare provider based in Salem, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/25/2006. The National Provider Identifier (NPI) number assigned to this provider is 1871600601.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. James Parosa, M.D has received a total of $1,205 in payments from pharmaceutical and medical device companies, with $242.68 received in 2023. These payments were reported across 59 transactions from 24 companies. The most common payment nature is "Food and Beverage" ($1,205).
As a Medicare-enrolled provider, Parosa has provided services to 428 Medicare beneficiaries, totaling 515 services with total Medicare billing of $32,026. Data is available for 4 years (2020–2023), covering 16 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Location Salem, OR
- Active Since 08/25/2006
- Last Updated 03/17/2018
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1871600601
Products in Payments
- DUPIXENT (Biological) $184.86
- WATCHMAN Access System (Device) $140.66
- TYVASO (Drug) $89.82
- TEZSPIRE (Biological) $86.89
- OPSUMIT (Drug) $68.82
- NUCALA (Biological) $56.58
- SPIRIVA RESPIMAT (Drug) $42.15
- BREZTRI (Drug) $40.40
- PREVNAR 20 (Biological) $39.39
- Xolair (Biological) $37.74
- Prolastin-C Liquid (Biological) $32.89
- EMGALITY (Drug) $31.19
- EVENITY (Biological) $27.02
- TRELEGY ELLIPTA (Drug) $26.73
- Rybelsus (Drug) $21.28
- TAGRISSO (Drug) $21.16
- SPRAVATO (Drug) $20.83
- Cologuard Collection Kit (Device) $20.12
- SOLIQUA 100/33 (Biological) $19.94
- Adempas (Drug) $19.71
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Salem
James Witten, Md, MD
Pulmonary Disease — Payments: $167,998
Pulmonary Disease $167,998
David Killeen, D.o, D.O
Pulmonary Disease — Payments: $132,565
Pulmonary Disease $132,565
Nelson Greene, Md, MD
Pulmonary Disease — Payments: $33,883
Pulmonary Disease $33,883
Douglas Dorsey, M.d, M.D
Pulmonary Disease — Payments: $24,524
Pulmonary Disease $24,524
Matthew Cheng, Md, MD
Pulmonary Disease — Payments: $15,201
Pulmonary Disease $15,201
Steven Marvel, M.d, M.D
Pulmonary Disease — Payments: $11,509
Pulmonary Disease $11,509